Photon-Counting Computed Tomography-Based Urethral Visualization Without Catheterization for Radiotherapy Planning: A Prospective Pilot Study Under ANTHEM
NCT07730203 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2026-07-28
Summary
In prostate cancer radiotherapy, it is important to accurately identify and protect healthy organs near the prostate. One of these structures is the urethra, the tube that carries urine from the bladder out of the body. If the urethra receives too much radiation, patients may experience urinary side effects.
Current CT scans used for treatment planning do not clearly show the urethra unless a urinary catheter is inserted. While a catheter can improve visibility, it may cause discomfort, increase the risk of infection, and slightly change the natural position of the urethra. MRI scans can also help visualize the urethra, but they are not always available and may not fit easily into all treatment workflows.
Photon-counting CT (PCCT) is a new type of CT scanner that produces higher-quality images with better detail. This technology may allow doctors to see the urethra without using a catheter.
The purpose of this pilot study is to investigate whether PCCT can reliably visualize the urethra in prostate cancer patients without the need for catheter insertion. If successful, this approach could make treatment planning more comfortable and less invasive while helping doctors better protect healthy tissues during radiotherapy.
Conditions
Interventions
- OTHER
-
image acquisition
Two sets of images will be acquired on TC photon counting: the first without a catheter, and the second after catheter placement by healthcare personnel. Comparison between images with and without catheter
Sponsors & Collaborators
-
Istituto Clinico Humanitas
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-22
- Primary Completion
- 2026-12-31
- Completion
- 2026-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins
NCT06665932 ·Status: RECRUITING ·Phase: NA
-
24 Gy in One Fraction Urethral-sparing "HDR Like" SBRT for Prostate Cancer
NCT05936736 ·Status: RECRUITING ·Phase: NA
-
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma
NCT00230386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical
NCT04831307 ·Status: UNKNOWN ·Phase: NA
-
ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0
NCT07407608 ·Status: RECRUITING
-
PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate Cancer
NCT04983459 ·Status: COMPLETED
-
Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy
NCT01830166 ·Status: UNKNOWN ·Phase: NA
-
Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage
NCT04116086 ·Status: UNKNOWN ·Phase: NA
-
Research on Real-time Proton Therapy Guidance Through Monitoring Proton Range Using All-digital PET
NCT07450560 ·Status: ACTIVE_NOT_RECRUITING
-
SBRT in 4 Fractions for Prostate Cancer
NCT03873090 ·Status: COMPLETED ·Phase: NA
-
Xray Volume Imaging (Cone Beam CT) - Prostate Cancer
NCT00188799 ·Status: COMPLETED ·Phase: PHASE2
-
177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer
NCT03403595 ·Status: UNKNOWN ·Phase: PHASE1
-
Cone Beam CT for Daily Image Guidance - Prostate Cancer
NCT00188786 ·Status: COMPLETED ·Phase: PHASE2
-
Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma
NCT02264379 ·Status: COMPLETED
-
Hypofractionated Radiotherapy for Prostate Cancer
NCT02311049 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term High Precision Radiotherapy for Early Prostate Cancer With Concomitant Boost on the Dominant Lesion
NCT01913717 ·Status: UNKNOWN ·Phase: NA
-
F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer
NCT00963755 ·Status: COMPLETED
-
Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer
NCT03073395 ·Status: COMPLETED ·Phase: PHASE1
-
Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate
NCT00585962 ·Status: COMPLETED ·Phase: PHASE2
-
Theranostic Applications of Radionuclides in Prostate Cancer
NCT07559201 ·Status: RECRUITING ·Phase: NA
-
Carbon Ions Boost Followed by Pelvic Photon Radiotherapy for High Risk Prostate Cancer
NCT02672449 ·Status: UNKNOWN ·Phase: NA
-
POst-Prostatectomy Ablative Radiation Therapy
NCT04831970 ·Status: RECRUITING
-
External Beam Radiation Therapy - Target Volume
NCT00230438 ·Status: COMPLETED ·Phase: PHASE2
-
177Lu-PSMA-EB-01 in Patients With Metastatic Castration-resistant Prostate Cancer
NCT05613738 ·Status: RECRUITING ·Phase: NA
-
PSMA-PET Guided Radiotherapy
NCT03525288 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3